ELIANE SANDRINE FANKAM: Open Payments
NPI 1629618624 · BURTONSVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,392 in 58 payments from 11 companies in 2025. Trend: 2023 $1,006 · 2024 $1,501 · 2025 $1,392
Food & beverage: $1,392
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 8 | $268 |
| Lundbeck LLC | 11 | $211 |
| Vanda Pharmaceuticals Inc. | 6 | $195 |
| Otsuka America Pharmaceutical, Inc. | 8 | $161 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $149 |
| Neurocrine BioSciences, Inc. | 4 | $116 |
| Teva Pharmaceuticals USA, Inc. | 4 | $83 |
| Alkermes, Inc. | 4 | $76 |
| ABBVIE INC. | 2 | $56 |
| Axsome Therapeutics, Inc. | 2 | $39 |
Products named: ABILIFY ASIMTUFII, INVEGA SUSTENNA, CAPLYTA, HETLIOZ, INGREZZA, REXULTI, UZEDY, FANAPT.
Industry payments across MD — which companies pay providers there.
